IBRX
IMMUNITYBIO INC
Health Care·Biotechnology·UNITED STATES
$8.08
MCap $8.6B
as of 2026-09-04
Total
C2w
Fund
C10w
Quant
C2w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.22
Sentiment 72.1%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$8.08
Adaptive Mean
$8.13
-0.05 vs mean
Adaptive σ
0.12
MIDOS BB
$7.90 – $8.37
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
-0.73
ROE
—
Z —
Rev Gr
93.9%
Z +1.11
EPS Gr
—
Z +0.07
OPM Gr
149.4%
Z +0.05
FCF Yld
-2.2%
Z -0.15
EPS Surp
-1.8%
Z -5.64
EPS 3mo Δ
28.6%
Z +0.16
Fwd P/E
-63.79
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
5.89
Q6M
-2.75
Q12M
8.40
MA 30/100
0.992
Bearish (MA30 < MA100)
α (Jensen)
0.5992
β (12M)
1.71
σ (12M)
1.045
Divergence — Fundamentals vs Momentum
Z Percentile
6%
Q Percentile
94%
Divergence
-87.8
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
-32.4
RS Pctl
14%
RS Decile
D2
Persistence
2w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.